GPTHEALTH Reports Results for the Fourth Quarter ended on Mar 25

GPT Healthcare Limited (BSE: 544131; NSE: GPTHEALTH) reported its financial result for the fourth quarter ended Mar 31, 2025. During the Q4 FY25, the total income stood at Rs. 103.0 crores with EBITDA at Rs. 22.2 crores. The Net profit stood at Rs. 12.8 crores in Q4 FY25 with PAT margin of 12.4%.

Key Financial Highlights for FY25:

- Total Income stood at 415.6 crores, higher by 2.5% y-o-y
- EBITDA stood at Rs. 91.9 crores, with EBITDA margin of 22.1%
- PAT stood at Rs. 50.0 crores, PAT margin of 12.0%
- The Total Dividend declared for FY 2024-25 of Rs. 2.5 per share, including final dividend of Rs 1.5 per share

Commenting on the performance, GPT Healthcare Chairman, Mr. Dwarika Prasad Tantia, said, "We have always focused on strong operational and financial parameters and this is reflective in our results for the quarter despite the changing case mix across all hospitals.

The existing four hospitals in Salt Lake, Agartala, Dum Dum and Howrah, continue to perform well and are improving on all financial and operational metrics and reducing ALOS. The ARPOB for Q4FY25 was Rs.37,180 which is in line with our policy of serving the aspiring population of the society with higher disposable income in the middle to high income segment. The payer mix continues to be mostly cash and insurance.

With a focused geographical presence in eastern India, an under-penetrated region in terms of quality healthcare, GPT Healthcare stands as a beacon of excellence. Despite our rapid growth, our dedication to patient care, professional integrity, and medical excellence remains unwavering, only strengthening with time.

Our long-term vision at GPT Healthcare is deeply rooted in our commitment to bringing advanced medical care to under-served markets in cities across eastern India. We aim to establish a chain of 150 to 200-bedded hospitals in these burgeoning markets, thereby fulfilling the pressing need for modern healthcare facilities in these areas.

We are committed to becoming a 1,000-bed hospital chain within the next 2-3 years. As part of this vision, we commissioned a 158-bed multi-specialty hospital at Pachpedi Naka, Raipur on 2nd May 2025, under an asset-light, rental-based model with a Rs. 55 crore investment. Serving Raipur and nearby districts including Bilaspur, Durg, and Bhilai, the facility offers advanced care across Cardiac Sciences, Oncology, Neurology, Orthopaedics, Paediatrics, and more. It is equipped with state-of-the-art technology including a 3 Tesla MRI, 128-slice Dual Source CT, Cardiac Cath Lab, and 5 modular OTs. Designed for quaternary care and complex treatments, the hospital is backed by a highly skilled team & has been fully commissioned.

Additionally, we have signed an MoU for a hospital in Jamshedpur, with a planned capacity of 150 beds and an estimated cost of approximately Rs. 74 Cr. The hospital is expected to be commissioned by the end of FY27. Furthermore, we commenced robotic knee surgeries at our Howrah hospital and performed 12 such procedures in Q4FY25.

By strategically expanding our presence and offering advanced medical services in these underserved regions, we not only aim to meet the evolving healthcare needs of the populace but also contribute to the overall development and well-being of these communities. Our vision is to become a trusted healthcare partner, providing accessible, highquality medical care to every individual, regardless of their geographic location or socio-economic background."

Shares of GPT Healthcare Limited was last trading in BSE at Rs. 155.90 as compared to the previous close of Rs. 155.00. The total number of shares traded during the day was 23268 in over 622 trades.

The stock hit an intraday high of Rs. 158.90 and intraday low of 154.70. The net turnover during the day was Rs. 3661131.00.

Source : Equity Bulls

Keywords

GPTHealthcare INE486R01017 Hospital ILSHospitals Q4FY25 FY2025 ResultUpdate